One twin got colon cancer at 21. The other didn't. Their story illustrates the mysterious nature of the rise of colon cancer ...
Good morning, and welcome to the PAVmed's Third Quarter 2025 Business Update Conference Call. [Operator Instructions] This call is being recorded on Thursday, November 13, 2025. I would now like to ...
Dr. Joshua Sabari sat down with Dr. Michael Cecchini to discuss advances in colorectal cancer management and key data ...
There's a new frontier in treating autoimmune diseases. Today's treatments tamp down the friendly fire but don't fix what's ...
PAVmed Inc. (NASDAQ: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results